Crossmark

A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis

Crossref DOI link: https://doi.org/10.1007/s12325-023-02488-z

Published Online: 2023-03-31

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cichewicz, Allie https://orcid.org/0000-0002-8528-9901
Tencer, Tom

Gupte-Singh, Komal

Egodage, Sonya

Burnett, Heather https://orcid.org/0000-0003-1269-4276
Kumar, Jinender
Funding

Funding for this research was provided by:

Bristol-Myers Squibb
License Information

Text and Data Mining valid from 2023-03-31

Version of Record valid from 2023-03-31
More Information

Article History

Received: 3 November 2022

Accepted: 6 March 2023

First Online: 31 March 2023

Document is current

Any future updates will be listed below